Table 1.
Baseline characteristics of the participants in the PPS population.
| Placebo (n = 47) | Probiotics (n = 47) | p Value | |
|---|---|---|---|
| Mean ± SD | Mean ± SD | ||
| Age | 50.11 ± 7.21 | 50.43 ± 7.59 | 0.835 b |
| Sex (Male/Female) | 33/14 | 33/14 | 1.000 c |
| Total fat area (cm2) a | 315.68 ± 68.52 | 316.61 ± 58.16 | 0.953 b |
| Visceral fat area (cm2) a | 112.77 ± 36.61 | 115.32 ± 35.91 | 0.741 b |
| Subcutaneous fat area (cm2) a | 202.91 ± 37.80 | 201.28 ± 35.65 | 0.904 b |
| Body fat mass (kg) | 22.45 ± 4.68 | 22.55 ± 5.07 | 0.928 b |
| Body fat percentage (%) | 30.65 ± 6.83 | 30.83 ± 7.22 | 0.903 b |
| Body weight (kg) | 73.74 ± 7.69 | 73.55 ± 7.51 | 0.900 b |
| BMI (kg/m2) | 26.02 ± 1.87 | 26.20 ± 1.77 | 0.643 b |
a: Three participants in the placebo group and two participants in the probiotics group were excluded due to missing CT data. b: p values determined by a two-sample t test. c: p values determined by Fisher’s exact test.